{
    "2020-04-14": [
        [
            {
                "time": "2020-04-14",
                "original_text": "格隆汇港股聚焦(4.14)︱中国人寿一季度保费收入3078亿元小米耗资2.5亿港元回购2455万股",
                "features": {
                    "keywords": [
                        "中国人寿",
                        "保费收入",
                        "小米",
                        "回购"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "复星医药：子公司获药品补充申请批件 新药适用于类风湿关节炎等治疗",
                "features": {
                    "keywords": [
                        "复星医药",
                        "药品补充申请",
                        "类风湿关节炎"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "晚间公告热点追踪：中信证券澄清与中信建投合并传闻",
                "features": {
                    "keywords": [
                        "中信证券",
                        "中信建投",
                        "合并传闻"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "复星医药(02196)：复宏汉霖拟为汉霖制药不超过2亿元贷款提供担保 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复宏汉霖",
                        "贷款担保"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "两种新冠病毒灭活疫苗进入临床试验 国产疫苗研发加速推进",
                "features": {
                    "keywords": [
                        "新冠病毒",
                        "灭活疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "复星医药(02196)子公司收到关于利妥昔单抗注射液的药品补充申请批件",
                "features": {
                    "keywords": [
                        "复星医药",
                        "利妥昔单抗",
                        "药品补充申请"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "医药生物行业今日涨1.74%，主力资金净流出4.50亿元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "主力资金",
                        "净流出"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "恒指冲高回落收涨0.56% 医药板块活跃",
                "features": {
                    "keywords": [
                        "恒指",
                        "医药板块",
                        "活跃"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-04-14",
                "original_text": "国药集团武汉所研发 全球首个新冠病毒灭活疫苗进入临床",
                "features": {
                    "keywords": [
                        "国药集团",
                        "新冠病毒",
                        "灭活疫苗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}